- Home
- BKTI vs NGEN Comparison
BKTI vs NGEN Comparison
Compare BKTI & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKTI | NGEN |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.7M | 317.6M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | BKTI | NGEN |
|---|---|---|
| Price | $83.63 | $4.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $74.00 | N/A |
| AVG Volume (30 Days) | 23.3K | ★ 142.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 446.15 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $74,094,000.00 | N/A |
| Revenue This Year | $12.00 | N/A |
| Revenue Next Year | $11.30 | N/A |
| P/E Ratio | $35.96 | ★ N/A |
| Revenue Growth | ★ 45.42 | N/A |
| 52 Week Low | $26.20 | $3.73 |
| 52 Week High | $89.23 | $5.93 |
Technical Indicators
Market Signals| Indicator | BKTI | NGEN |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 38.04 |
| Support Level | $73.89 | $3.76 |
| Resistance Level | $85.06 | $4.29 |
| Average True Range (ATR) | 3.92 | 0.27 |
| MACD | 0.43 | 0.07 |
| Stochastic Oscillator | 84.24 | 55.00 |
Price Performance
Historical ComparisonAbout BKTI BK Technologies Corporation
BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
About NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.